| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |